I will compile a spreadsheet with combined holdings next week unless someone else does it first |
65 share/stake holders of DA ? |
kk/ 362019 - perhaps someone has the totals and percentages calculated?
Companies House/ Device Authority / Confirmation Statement / March 4, 2025
04 Mar 2025 Confirmation statement made on 21 February 2025 with updates
View PDF Confirmation statement made on 21 February 2025 with updates - link opens in a new window - 9 pages(9 pages) |
Has anyone got the figures of who owns DA |
Steve
Try ringing tern ?
None of the phones work |
I THANK YOU!!!! |
And whi was right all along???? |
Why does Tern not answer
any of the phone numbers
it has listed !!!
Is that not a reflection of
how badly run this company is !! |
I suspect that Talking Medicines with their "women-led" management are anything but average and will be exceeding any other "average performance, albeit already 35% higher"
[IMO / I have not met any of the TM team - opinion developed from Webinars, Press and Social Media]
Talking Medicines
".......with women-led businesses delivering, on average, 35% higher returns on investment. At Talking Medicines, we are not just focused on growth—we are focused on building a sustainable, inclusive, and innovative future." |
 Article at Post 362015 continued - captured for the BB.
Expanding to the U.S.
Expanding into the U.S. was a natural step for Talking Medicines. With operations in NYC, New Jersey and participation in Scottish Enterprise’s Market Booster program in Silicon Valley, we are building the connections and insights needed to scale effectively. Breaking into a new market is not just about opportunity—it is about understanding local business culture, industry sector needs and regulations. By immersing ourselves in the U.S. healthcare and data technology landscape, we are positioning Talking Medicines as a global leader in data-driven health solutions.
Building Relationships and Learning from Others
Strong relationships are the foundation of success. At Talking Medicines, we believe in working closely with government bodies, social enterprises, and commercial organizations to create a stronger ecosystem for entrepreneurs. Gender diversity is another critical factor. Research shows that gender-diverse teams are their less diverse counterparts. That is why we are committed to fostering balance across all levels—from teams to board positions to investor partnerships. A great example of this strength is our Ops Leadership Team, which includes Jo Halliday, Dr. Elizabeth Fairley, Scott Crae, Roma English Owen, and Ellie Halliday. Their collective expertise and dedication drive our mission forward every day.
A Look Ahead
As International Women’s Day passes, we are reflecting on the power of resilience, strategic thinking, and collaboration. Female entrepreneurs are reshaping industries and driving economic growth, with women-led businesses delivering, on average, 35% higher returns on investment. At Talking Medicines, we are not just focused on growth—we are focused on building a sustainable, inclusive, and innovative future. By continuing to scale internationally, collaborating across industries, and championing diversity, we are proving that success is about working together to create lasting impact. |
Anyone got TB email address.
worth a shot. Tern bod don't seem to be able to sell water in the desert.. |
"Building a successful business in today’s fast-paced world requires vision, strategy, and the right support at every stage of growth." |
hxxps://deviceauthority.com/the-purdue-enterprise-reference-architecture-strengthening-iot-and-ot-security-in-industrial-environments-2/
In partnership with Baker Hughes, we developed a Remote Access Controller (RAC) tailored to constrained environments, such as devices with limited memory capacities (e.g., 100MB). By adhering to Purdue’s segmentation principles and embedding advanced identity management and authentication features, the RAC ensures secure remote access without compromising performance or compliance. This solution highlights the importance of integrating robust security measures into every layer of the Purdue model, especially as remote operations become standard in industrial settings. |
Well if there is ever an offer, we'll find out. No real idea of value, and think we're all guessing, could be huge or not! |
Thoma Bravo news - amasses $2bn for its first European fund
Opalesque
Thoma Bravo amasses $2bn for its first European fund
Thursday, March 13, 2025
Laxman Pai, Opalesque Asia:
Technology-focused investment manager Thoma Bravo has closed its inaugural European fund at €1.8 billion ($1.96 billion), through which it plans to take equity stakes in mid-sized software companies across the continent.
The American private equity and growth capital firm that specializes in software deals said in a press note that the Europe Fund seeks to make equity investments in innovative, middle-market software businesses across core European software markets to support founders, entrepreneurs, and management teams in scaling their businesses into European industry leaders.
"Our first dedicated pool of capital for European software marks a significant milestone for our firm," said Orlando Bravo, a Founder and Managing Partner at Thoma Bravo. "We see an enormous opportunity to back Europe's technology innovators and help them scale, and we are grateful for the long-term support of our investors in realizing this ambition."
Article continues.... |
I know 3p may seem a long way off but Circa £18M for Terns assets seems to be under selling it somewhat lol |
3p area, having a laugh when DA are partners of equals in this new solution and remember its in two sectors not just one.
Sometime in the next year that long awaited pot of gold at the end of the rainbow will be found |
Check out NARF guys the SAAS model is going to send it ballistic |
bingoprize, I'm in that camp. Would be nice to do that in the 3p area, depending. All relies on an exit however from DA, which is a complete unknown. |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
